Vaginal Fluid Markers for Early Detection of Gynecological Cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This study collects vaginal fluid samples to test whether certain biological markers (substances in the fluid) can help detect gynecological cancers earlier or track how they change during treatment. You may qualify if you're being evaluated for, currently receiving treatment for, or receiving comfort care for a gynecological cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You are undergoing investigation for suspected gynecological cancer, or have a confirmed gynecological cancer diagnosis and are receiving treatment or palliative (comfort) care
- You do not have a vaginal infection right now
- You have not taken antibiotics in the past 7 days
- You do not have a history of other cancers or chronic inflammatory diseases (like inflammatory bowel disease)
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study checks whether a sample of fluid from the uterus (uterine lavage) can help detect ovarian or fallopian tube cancer. You may join if you are having certain gynecologic surgeries or, in a smaller group, you have a BRCA1/2 mutation.
This study tests a new device that collects a sample from the vagina to look for signs of womb (endometrial) or ovarian cancer. It may offer a simpler way to check for these cancers compared to current methods.
This study looks at tumor tissue and blood samples to find biological “markers” in people with gynecologic cancers. It may help researchers understand disease better and could guide future, more personalized treatments.
This study tests whether DNA markers in vaginal fluid can help detect endometrial cancer. You'll provide a sample and take part in a virtual interview.
This study looks at proteins in urine to help find ovarian cancer earlier and track how the disease changes. It aims to provide a non-invasive way to tell the difference between benign and malignant pelvic masses.
Hear when a new Gynaecological Cancers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.